MétaCan
Menu
Back to cohort
Record W2972198719 · doi:10.1161/hyp.74.suppl_1.p156

Abstract P156: Long-Term Blood Pressure Outcomes and Costs Associated With a Barber-Pharmacist Hypertension Intervention: 10-Year Simulation of the Los Angeles Barber Trial

2019· article· en· W2972198719 on OpenAlexaff
Kelsey B. Bryant, Dhruv S. Kazi, Valy Fontil, Joanne Penko, Ciantel A. Blyler, Kathleen Lynch, Joseph E. Ebinger, Norma B Moy, Florian Rader, Kirsten Bibbins‐Domingo, Andrew E. Moran, Brandon K. Bellows

Bibliographic record

VenueHypertension · 2019
Typearticle
Languageen
FieldEconomics, Econometrics and Finance
TopicHealth Systems, Economic Evaluations, Quality of Life
Canadian institutionsBrandon University
Fundersnot available
KeywordsMedicinePharmacistBlood pressureIntervention (counseling)Confidence intervalPhysical therapyEmergency medicineFamily medicineNursingInternal medicinePharmacy

Abstract

fetched live from OpenAlex

Background: Barber-pharmacist blood pressure (BP) management reduced systolic BP >20 mm Hg compared to education alone over one year in Non-Hispanic (NH) black men with uncontrolled hypertension (HTN) in the Los Angeles BARBER (LA-BARBER) Trial. Long-term BP outcomes and costs of this intervention are unknown. Objective: Simulate 10-year BP outcomes and intervention and medication costs of a one-year barber-pharmacist HTN intervention followed by usual care compared to usual care alone. Methods: We simulated 1000 LA BARBER-eligible NH black men sampled from the National Health and Nutrition Examination Survey. We used a discrete event simulation version of the validated BP Control Model to predict BP outcomes over 10 years. Model inputs were derived from published literature, national sources, LA-BARBER individual participant data, and interviews with LA-BARBER intervention pharmacists. Medication and intervention (clinical care, travel, and administrative time) costs were calculated from a 2018 US payer perspective and discounted 3% annually. Primary outcomes were percent with BP <130/80 mm Hg, medication and intervention costs, and the cost per patient with BP controlled. We used 100 probabilistic model iterations to examine parameter uncertainty. Results: Our calibrated model accurately reproduced baseline characteristics and predicted 1-year BP outcomes of the LA-BARBER study (mean age 54 years, baseline BP 153/91 mm Hg, 69% predicted 1-year BP control with the barber-pharmacist HTN intervention). Over 10 years, 64% of patients (95% uncertainty interval [UI] 61%-67%) were predicted to achieve BP control with the barber-pharmacist HTN intervention compared to 38% (95% UI 26%-48%) with usual care. Projected intervention and medication costs were $8084 (95% UI $7664-$8598) with the barber-pharmacist intervention compared to $4183 ($3514-$4768) with usual care costing $15,000 per controlled patient gained. Conclusions: Medication and intervention costs for a barber-pharmacist HTN intervention were about double usual care, but it achieved substantially higher BP control rates. Ongoing research will examine if this strategy meets traditional cost-effectiveness thresholds (e.g.,<$100,000 per quality-adjusted life year).

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.013
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Simulation or modeling · Consensus signal: Simulation or modeling
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.081
Threshold uncertainty score0.161

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.013
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0010.001
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0030.001
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0080.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.200
GPT teacher head0.376
Teacher spread0.176 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSimulation or modeling
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueHypertensionSame topicHealth Systems, Economic Evaluations, Quality of LifeFrench-language works237,207